Kayne Anderson Rudnick Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Buy |
|
|||||
|
2025
Q1 | $523K | Sell |
|
|||||
|
2024
Q4 | $462K | Sell |
|
|||||
|
2024
Q3 | $648K | Sell |
|
|||||
|
2024
Q2 | $745K | Sell |
|
|||||
|
2024
Q1 | $859K | Sell |
|
|||||
|
2023
Q4 | $790K | Sell |
|
|||||
|
2023
Q3 | $786K | Buy |
|
|||||
|
2023
Q2 | $741K | Buy |
|
|||||
|
2023
Q1 | $721K | Sell |
|
|||||
|
2022
Q4 | $720K | Buy |
|
|||||
|
2022
Q3 | $530K | Sell |
|
|||||
|
2022
Q2 | $1.07M | Buy |
|
|||||
|
2022
Q1 | $1.06M | Sell |
|
|||||
|
2021
Q4 | $1.1M | Sell |
|
|||||
|
2021
Q3 | $956K | Buy |
|
|||||
|
2021
Q2 | $969K | Sell |
|
|||||
|
2021
Q1 | $921K | Sell |
|
|||||
|
2020
Q4 | $12.7M | Sell |
|
|||||
|
2020
Q3 | $14.6M | Buy |
|
|||||
|
2020
Q2 | $8.41M | Sell |
|
|||||
|
2020
Q1 | $8.09M | Buy |
|
|||||
|
2019
Q4 | $9.66M | Sell |
|
|||||
|
2019
Q3 | $13.8M | Sell |
|
|||||
|
2019
Q2 | $13.4M | Buy |
|
|||||
|
2019
Q1 | $12.9M | Buy |
|
|||||
|
2018
Q4 | $11.4M | Sell |
|
|||||
|
2018
Q3 | $13.8M | Sell |
|
|||||
|
2018
Q2 | $14M | Sell |
|
|||||
|
2018
Q1 | $17.6M | Buy |
|
|||||
|
2017
Q4 | $13.1M | Sell |
|
|||||
|
2017
Q3 | $17.1M | Sell |
|
|||||
|
2017
Q2 | $18.8M | Buy |
|
|||||
|
2017
Q1 | $16.3M | Buy |
|
|||||
|
2016
Q4 | $12.3M | Sell |
|
|||||
|
2016
Q3 | $14.6M | Buy |
|
|||||
|
2016
Q2 | $3.81M | Buy |
|
|||||
|
2016
Q1 | $3.52M | Sell |
|
|||||
|
2015
Q4 | $3.63M | Sell |
|
|||||
|
2015
Q3 | $3.92M | Buy |
|
|||||
|
2015
Q2 | $4.06M | Buy |
|
|||||
|
2015
Q1 | $4.06M | Buy |
|
|||||
|
2014
Q4 | $2.9M | Buy |
|
|||||
|
2014
Q3 | $2.42M | Buy |
|
|||||
|
2014
Q2 | $2.25M | Buy |
|
|||||
|
2014
Q1 | $1.95M | Buy |
|
|||||
|
2013
Q4 | $1.69M | Buy |
|
|||||
|
2013
Q3 | $1.3M | Buy |
|
|||||
|
2013
Q2 | $1.21M | Buy |
|